National Bank of Canada FI Reduces Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)
National Bank of Canada FI lowered its position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 96.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 441 shares of the company’s stock after selling 13,235 shares during the quarter. […]
National Bank of Canada FI lowered its position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 96.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 441 shares of the company’s stock after selling 13,235 shares during the quarter. […]
